Clinical characteristics of patients with ischemic ocular nerve palsies and lacunar brain infarcts: A retrospective comparative study

Acta Neurologica Scandinavica

Volumn 111, Issue 5, 2005, Pages 333-337

  Pollak, Lea ^a,d   Kessler, A ^b   Rabey, M J ^a   Hartmann, B ^a   Goldhammer, Y ^c  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d NONE   (Israel)

Author keywords

Aspirin; Ischemic ocular nerve palsies; Lacunar brain infarcts

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

ADULT; AGED; ARTERIOSCLEROSIS; ARTICLE; BELL PALSY; BRAIN INFARCTION; CAROTID ARTERY OBSTRUCTION; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEART ARRHYTHMIA; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; OPHTHALMOPLEGIA; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTERIOSCLEROSIS; ASPIRIN; BRAIN INFARCTION; FEMALE; HUMANS; MALE; OPTIC NEUROPATHY, ISCHEMIC; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 17644400724     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2005.00409.x     Document Type: Article

References (27)

1. ASBURY AK, ALDREDGE H, HERSHBERG R, FISHER CM. Oculomotor palsy in diabetes mellitus: a clinico-pathological study. Brain 1970;93:555-66.
2. WEBER RB, DARO RB, MACKEY EA. Pathology of oculomotor nerve palsy in diabetics. Neurology 1970;20:835-8.
3. MOHR JP, MARTI-VILALTA JL. Lacunes. In: BARNETT HJM, MOHR JP, STEIN BM, YATSU FMT, eds. Stroke, pathophysiology, diagnosis, and management, 3rd edn. New York: Churchill Livingstone, 1998;599-622.
4. TEUSCHER AU, MEIENBERG O. Ischaemic oculomotor nerve palsy. Clinical features and vascular risk factors in 23 patients. J Neurol 1985;232:144-9.
5. RA MC, ASBURY AK. Ischemic mononeuropathy and mononeuropathy multiplex in diabetes mellitus. N Engl J Med 1968;279:17-22.
6. JACOBSON DM, MCCANNA TD, LAYDE PM. Risk factors for ischemic ocular motor nerve palsies. Arch Ophthalmol 1994;112:961-6.
7. JACOBSON DM. Progressive ophthalmoplegia with acute ischemic abducens nerve palsies. Am J Ophthalmol 1996;122:278-9.
8. ARBOIX A, MARTI-VILALTA JL. Transient ischemic attacks in lacunar infarct. Cerebrovasc Dis 1991;1:20.
9. HOPF HC, GUTMANN L. Diabetic 3rd nerve palsy: evidence for a mesencephalic lesion. Neurology 1990;40:1041-5.
10. SAEKI N, MURAI H, MINE S, YAMAURA A. Fascicular arrangement within the oculomotor nerve MRI analysis of a midbram infarct. J Clin Neurosci 2000;7:268-70.
11. KOBASHI R, OHTSHUKI H, HASEBE S. Clinical studies of ocular motility disturbances. Jpn J Ophthalmol 1996;40:502-10.
12. KIM JS, KANG JK, LEE SA, LEE MC. Isolated or predominant ocular motor nerve palsy as a manifestation of brain stem stroke. Stroke 1993;24:581-6.
13. KAPELLE LJ, VAN LATUM JC, KOUDSTAAL PJ, VAN GIJN J. Transient ischaemic attacks and small-vessel disease. Lancet 1991;337:339-41.
14. SANDERS SK, KAWASAKI A, PURVIN VA. Long-term prognosis in patients with vasculopathic sixth nerve palsy. Am J Ophthalmol 2002;134:81-4.
15. SACCO SE, WHISNANT JP, BRODERICK JP, PHILLIPS SJ, O'Fallon WM. Epidemiological characteristics of lacunar infarcts in a population. Stroke 1991;22:1236-41.
16. ZORILLA E, KOZAK G. Ophthalmoplegia in diabetes mellitus. Ann Int Med 1967;67:968-76.
17. ROSS AT. Recurrent cranial nerve palsies in diabetes mellitus. Neurology 1962;12:180-5.
18. CAKSEN H, ACAR N, ODABAS D, CAKIN C, TUNCER O, ATAS B. Isolated left oculomotor nerve palsy following measles. J Child Neurol 2002;17:784-5.
19. MILLER NR. Solitary oculomotor nerve palsy in childhood. Am J Ophthalmol 1977;83:106-11.
20. HERTENSTEIN JR, SARNAT HB, O'CONNOR DM. Acute unilateral oculomotor palsy associated with echo 9 viral infection. J Pediatr 1976;89:79-81.
21. BARINGER JR. Herpes simplex virus and Bell palsy. Ann Intern Med 1996;124:63-4.
22. JOHNSON LN, STETSON SW, KROHEL GB, CIPOLLO CL, MADSEN RW. Aspirin use and the prevention of acute ischemic cranial nerve palsy. Am J Ophthalmol 2000;129:367-71.
23. The Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med 1991;325:1261-6.
24. KAPPELLE JL, VAN LATUM JC, VAN SWIETEN JC, ALGRA A, KOUDSTAAL PJ, VAN GIJN J FOR THE DUTCH TIA TRIAL STUDY GROUP. Recurrent stroke after transient ischaemic attack or minor ischaemic stroke: does the distinction between small and large vessel disease remain true to type? J Neurol Neurosurg Psychiatry 1995;59:127-31.
25. BORNSTEIN NM, KAREPOV VG, ARONOVICH BD, GORBULEV AY, TREVES TA, KORCZYN AD. Failure of aspirin treatment after stroke. Stroke 1994;25:275-7.
26. CHIMOWITZ MI, FURLAN AJ, NAYAK S, SILA CA. Mechanism of stroke in patients taking aspirin. Neurology 1990;40:1682-5.
27. EMSLEY HCA, TYRRELL PJ. Inflammation and infection in clinical stroke. Review article. J Cereb Blood Flow Metab 2002;22:1399-419.